Sansanmycin F is a white amorphous powder; electrospray ionization (ESI)-MS m/z 904. 6 [M+H] + , HR-ESI-MS m/z 904. 36496 [M+H] + (calcd for C 43 H 54 N 9 O 11 S, 904.36635). 1 H and 13 C NMR spectra of Sansanmycin F (Table 1) were similar to those of Sansanmycin, 1 except that there were new signals in the NMR spectra of Sansanmycin F instead of m-tyrosine residue in Sansanmycin. A series of NMR ( 1 H NMR, 13 C NMR, 1 H-1 H COSY, heteronuclear multiple quantum coherence (HMQC) and heteronuclear multiple bond coherence (HMBC)) data indicated that it had the 1,1-dimethyl-6-hydroxy-1,2,3,4-tetradhydro-3-isoquinoline carboxylic acid (TIC) (Figure 2) as the blocked N terminus, similar to Napsamycin B, 5 which had 1-methyl-6-hydroxy-1,2,3,4-tetradhydro-3-isoquinoline carboxylic acid, and Mureidomycin F, 6 which had 6-hydroxy-1,2,3,4-tetradhydro-3-isoquinoline carboxylic acid as the blocked N terminus The total structure of Sansanmycin F was further confirmed by analysis of ESI-MS/MS spectra. The ESI-MS/MS data of the protonated molecular ion, m/z 904 (Figure 3) , indicated that sequence selective fragmentations observed for Sansanmycin F showed complete similarity to those of sansanmycin, 1 except those originating from the N terminus. The fragment ion m/z 176 also confirmed that Sansanmycin F had TIC as the N terminus.
Sansanmycin G is a white amorphous powder; ESI-MS m/z 886. 7 [M+H] + , HR-ESI-MS m/z 886.40338 [M+H] + (calcd for C 44 H 56 N 9 O 11 , 886.40993). Close examination of the 1 H and 13 C NMR data of Sansanmycin G suggested that it is similar to Sansanmycin F with a leucine moiety in place of the methionine unit. HPLC analyses of the alkaline hydrolysate (6 N NaOH, 110 1C, 16 h) of Sansanmycin G confirmed the presence of leucine residue. A series of 2D NMR experiments ( 1 H-1 H COSY, HMQC and HMBC) were performed, which allowed assignment of all 1 H and 13 C signals associated with each amino-acid unit and pseudo nucleoside residue (Table 1 ). The total structure of Sansanmycin G (Figure 1 ) was also further confirmed by analysis of ESI-MS/MS spectra ( Figure 3) . Sansanmycin F and G had weak antibacterial activity, as shown in Table 2 . Sansanmycin F exhibited inhibitory activity against P. aeruginosa with an MIC value of 16 mg ml À1 . Sansanmycin F and G were further evaluated for their inhibitory activity against Mycobacterium tuberculosis H 37 Rv, on the basis of alarm blue microplate assay, 7 with MIC values more than 16 mg ml À1 .
